# K050371: Medrad Vanguard DX Angiographic Catheter

- Pathway: 510(k) (Traditional)
- Applicant: Medrad, Inc.
- Decided: Jun 7, 2005 after 113 days
- Product code: DQO (Catheter, Intravascular, Diagnostic)
- Device class: 2
- Regulation: 21 CFR 870.1200
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
No predicates in its family tree.
No later device cites it as a predicate yet.
0 of 1 device in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- None. The FDA summary names no predicate by number.

## Indications for use
The Vanguard DxTM catheter is intended for use in the delivery of radiopaque contrast media and common flushing agents to the vascular system.

Source page: https://510kreport.com/device/K050371
Methodology: https://510kreport.com/methodology